跳至主要内容
临床试验/CTRI/2020/05/025360
CTRI/2020/05/025360尚未招募未知

Comparison of Less invasive surfactant administration and InSurE method on total duration of respiratory support in babies 26 to 34 weeks of gestation with RDS -An open label randomized control trial.

Department of Neonatology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All criteria to be full filled-
  • -Inborn preterm infant 26 weeks to 34 weeks of gestational age
  • -Infants with typical sign and symptoms of RDS
  • -Infants require nCPAP treatment with required fraction of inspired oxygen (FiO2)-0.4 or more in first 6 hours of life.

排除标准

  • Anyone of the following-
  • -Infants with major congenital anomalies.
  • -Severe birth asphyxia, Apgar score <4 and cord Ph < 7.0
  • -Required intubation in birthing area prior to first surfactant dose
  • -Shock prior to randomization
  • -No parental consent

研究者

发起方
Department of Neonatology

相似试验